Paris Brain Institute
Paris, France
Dr Verreault is a PhD scientist specialized in cellular and molecular biology of cancer at the Paris Brain Institute. Originally from Quebec city, she pursued her PhD at the University of British Columbia in Vancouver, where she quickly found an interest for the development experimental therapeutics for glioblastoma treatment. She has been working as a researcher with GlioTex since its beginnings in 2012 and is now in charge of the scientific management of industrial and academic collaborations. Her work focuses on the evaluation on innovative therapies for glioblastoma and the identification of new therapeutic targets thanks to pre-clinical models established by GlioTex.